5RN-32153-20869
4 vaccinations
3 coded responses
36 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 967 / HI
- Registered
- 2021-09-08
- Relationship
- Adult relative or friend
- Guardian
- XZE-57815-03385
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-08
Registered in v-safe
-
2021-09-08
Dose 1 — Pfizer-BioNTech
- 2021-09-08
-
2021-09-09
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-09-11
- 2021-09-12
- 2021-09-13
- 2021-09-14
- 2021-09-15
- 2021-09-22
-
2021-09-29
Dose 2 — Pfizer-BioNTech
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-29
- 2021-11-03
- 2021-11-10
- 2021-12-29
- 2022-03-30
-
2022-08-17
Dose 3 — Pfizer-BioNTech
-
2022-08-19
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-08-20
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2022-08-21
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Site: Pain · Muscle or body achesAdult check-in
-
2022-08-22
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Injection site discolouration — Feeling: GoodFree text: Injection site is black and blueMedDRA releases: 2024-11 · check-in free text available
-
2022-08-24
Survey response — day 7, dose 3, dependentMedDRA: Injection site bruising — Feeling: Good · Site: ItchingFree text: Injection site still bruisedMedDRA releases: 2024-11 · check-in free text available
- 2022-09-01
- 2022-09-07
- 2022-09-16
- 2022-09-21
- 2022-09-29
- 2022-11-17
-
2023-02-01
Dose 4 — Pfizer-BioNTech
-
2023-02-15
Survey response — 6 months, dose 3, dependentMedDRA: Injection site pain, Injection site pruritus — Feeling: GoodMedDRA releases: 2024-11
- 2023-05-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-08 | Pfizer-BioNTech | No |
| 2 | 2021-09-29 | Pfizer-BioNTech | No |
| 3 | 2022-08-17 | Pfizer-BioNTech | No |
| 4 | 2023-02-01 | Pfizer-BioNTech | No |
Free text
Release 12 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): Injection site is black and blue
Release 12 — day 7, dose 3, dependent
Systemic reaction (other): Injection site still bruised
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site pain | · | · | ✓ |
| SD | Injection site pruritus | · | · | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
| SRO | Injection site discolouration | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release